Prion disease causes less severe lesions in human hippocampus than other parts of brain

Authors

Errata

This article is corrected by:

  1. Errata: Corrigendum Volume 62, Issue 5, 626, Article first published online: 29 September 2008

*Naoji Amano, MD, PhD, Department of Neuropsychiatry, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Email: n-amano@hsp.md.shinshu-u.ac.jp

Abstract

Aim:  The hippocampus can be very sensitive to damage in the scrapie-infected mouse, a well-established animal model of prion diseases. Terminally ill scrapie-infected animals exhibit nearly complete loss of cornu ammonis (CA) 1 pyramidal neurons, but few studies have focused on the neuropathological lesions of the human hippocampus in autopsied brain tissue; in particular, few findings on differences in severity of pathology between the hippocampal and parahippocampal formations have been obtained. The aim of the present paper is to evaluate the human hippocampus of prion disease through neuropathological examination.

Methods:  A systemic, detailed neuropathological study throughout the subdivisions of the hippocampus was carried out in 23 autopsied cases of prion diseases. Prion protein immunohistochemistry was performed in serial brain sections to determine the topography of prion deposits.

Results:  Compared to lesions in other brain regions, hippocampal lesions were mild, despite numerous prion deposits. The distribution of prion deposits did not appear to be correlated with neuropathological changes. The present findings differed from the hippocampal pathology observed in scrapie-infected mice. In addition, differences in neuropathological severity were observed within the hippocampal formation.

Conclusion:  The human hippocampus may be protected from the neurotoxic effects of prion deposits.

Ancillary